Title |
Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19)
|
---|---|
Published in |
Frontiers in immunology, June 2020
|
DOI | 10.3389/fimmu.2020.01451 |
Pubmed ID | |
Authors |
Ruben Manuel Luciano Colunga Biancatelli, Max Berrill, John D. Catravas, Paul E. Marik |
X Demographics
The data shown below were collected from the profiles of 1,168 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 177 | 15% |
Canada | 34 | 3% |
France | 32 | 3% |
United Kingdom | 26 | 2% |
Turkey | 14 | 1% |
Spain | 13 | 1% |
Australia | 12 | 1% |
India | 9 | <1% |
Italy | 9 | <1% |
Other | 107 | 9% |
Unknown | 735 | 63% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1078 | 92% |
Practitioners (doctors, other healthcare professionals) | 46 | 4% |
Scientists | 36 | 3% |
Science communicators (journalists, bloggers, editors) | 4 | <1% |
Unknown | 4 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 695 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 695 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 78 | 11% |
Student > Master | 72 | 10% |
Student > Bachelor | 71 | 10% |
Student > Ph. D. Student | 55 | 8% |
Student > Doctoral Student | 32 | 5% |
Other | 119 | 17% |
Unknown | 268 | 39% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 95 | 14% |
Biochemistry, Genetics and Molecular Biology | 67 | 10% |
Pharmacology, Toxicology and Pharmaceutical Science | 52 | 7% |
Nursing and Health Professions | 36 | 5% |
Agricultural and Biological Sciences | 36 | 5% |
Other | 110 | 16% |
Unknown | 299 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 969. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 April 2024.
All research outputs
#17,323
of 25,805,386 outputs
Outputs from Frontiers in immunology
#19
of 32,415 outputs
Outputs of similar age
#847
of 435,277 outputs
Outputs of similar age from Frontiers in immunology
#2
of 756 outputs
Altmetric has tracked 25,805,386 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,415 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 435,277 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 756 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.